Akiyuki Uzawa

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

Akiyuki Uzawa, Masahiro Mori, Kimihito Arai et al. · Multiple Sclerosis Journal · 2010 · 323 citations

Life Sciences, Immunology, Neurology +17

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 250 citations

Medicine, Pharmacotherapy, Pain Management +2

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Tadahiro Yonezu, Shoichi Ito, Masahiro Mori et al. · Multiple Sclerosis Journal · 2013 · 127 citations

Medicine, Neurology, Radiology +17